HOME >> BIOLOGY >> NEWS
New research: Soy germ isoflavones reduce bone loss

Minneapolis A new study published in this month's European Journal of Nutrition demonstrates a strong correlation between reducing bone loss in non-obese postmenopausal women and the dose-dependent effect of soy germ isoflavones, particularly SoyLife. These findings support previous scientific findings regarding soy isoflavones for post-menopausal women.

According to the authors of the study, "Osteoporosis is a health condition experienced by about one in three postmenopausal women, with estrogen deficiency often acting as the major cause. Hormone replacement therapy has been the most effective treatment for maintaining bone density. This treatment often has adverse side effects such as an increased risk for endometrial cancer and breast cancer."

"It is imperative to find natural, safe and effective alternatives for women to help maintain bone health after menopause without the risky side effects associated with long-term hormone replacement therapy use. This promising research is another step in advancing soy germ isoflavones as a safe, effective option," said Jocelyn Mathern, RD and Technical Specialist, Acatris.

The study aimed to examine the effects of a high-dose supplementation of soy germ isoflavones (84 and 126 mg SoyLife EXTRA/day) in slowing bone loss in 90 early postmenopausal Chinese women. Isoflavones are found predominately in soy products. Their structure and functions are similar to estrogen, and observational studies suggest that higher intakes of soy and soy products may lower the prevalence of osteoporosis.

Soy isoflavones have been supported by proprietary scientific studies to promote women's health, bone health, heart health, prostate health and cognitive function. A focus of the study, SoyLife is a range of ingredients from soy germ, rich in isoflavones. More than just an isoflavone concentrate, SoyLife offers the complete spectrum of natural soy compounds, the Soy MatrixTM, wh
'"/>

Contact: Nicole Tronolone
ntronolone@mww.com
312-853-3131
MWW Group
7-Jul-2006


Page: 1 2

Related biology news :

1. Multinational research: protecting ecology means understanding people, too
2. From clinical cancer research: rethinking therapeutic cancer vaccine trials
3. New diabetes research: Half of Americans have gene that affects how body burns sugar
4. UC Davis scientists groundbreaking research: Mate-attracting chemicals
5. VCU research: Magnetic nanoparticles for potential cancer treatment
6. New slant on vision research: Neurons sensitive to viewing angle
7. Warning from new SLU research: Usual test for vitamin deficiency can mislead doctors
8. Latest buzz in research: Intoxicated honey bees may clue scientists into drunken human behavior
9. Frontiers in cancer prevention research: Defeating cancer before it strikes
10. Touching research: How white blood cells navigate
11. New system of wastewater treatment could reduce the size of treatment plants by half

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/2/2019)... ... ... Stay on top of current hot topics through free webinars presented by leading experts ... be sure to register today to save your place! Participate in the discussion and ... webinars: , CLINICAL OPERATIONS , November 14 – Leveraging Technology and Data to Establish ...
(Date:10/30/2019)... ... October 30, 2019 , ... Amberdata ... venture capital firms, including Fenbushi Capital, DF Capital, Rising Tide Fund, and HWVP. ... enabling Amberdata to further accelerate its position as the leading data provider of ...
(Date:10/27/2019)... ... October 26, 2019 , ... Since 2010, The HOTH ... program. By prioritizing the success of their clients, they’ve earned a place on the ... row, and they’ve won many additional awards and accolades along the way. , Now, ...
Breaking Biology News(10 mins):
(Date:11/6/2019)... ... November 06, 2019 , ... ... and dialogue, today announces its East/West CEO conference to be held ... , Kicking off the week of the J.P. Morgan Healthcare Conference ...
(Date:11/5/2019)... ... , ... Focal Healthcare , an innovator of image-guided ... 2.0 prostate fusion biopsy solution. By combining information from multiparametric MRI (mpMRI) with ... across Europe the ability to perform targeted transrectal and transperineal prostate biopsies. , ...
(Date:11/2/2019)... ... 2019 , ... A clinical trial usually involves many different ... principal investigators, supply chain managers, manufacturers, IRT, CRAs and so on. Lack of ... data, potentially leading to patient risk. , By having a single source of ...
(Date:11/2/2019)... YORK (PRWEB) , ... October 31, 2019 , ... ... been released by pharma artificial intelligence pioneer tellic. drug360 brings tellic’s expertise ... This new tool allows researchers to quickly uncover relationships between genes, diseases, variants, ...
Breaking Biology Technology:
Cached News: